{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T03:14:24Z","timestamp":1776914064520,"version":"3.51.2"},"reference-count":25,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2024.2734","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T09:50:48Z","timestamp":1710928248000},"source":"Crossref","is-referenced-by-count":4,"title":["Elderberry interaction with pazopanib in a patient with soft\u2011tissue sarcoma: A case report and literature review"],"prefix":"10.3892","volume":"20","author":[{"given":"Nikki","family":"Agarwal","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology and Oncology, Cleveland Clinic Children's Hospitals, Cleveland, OH 44195, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Mangla","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, University Hospital Seidman Cancer Center, Cleveland, OH 44106, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"key20240417101843_b1-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/jnci\/djk130","article-title":"Potential drug interactions and duplicate prescriptions among cancer patients","volume":"99","author":"Riechelmann","year":"2007","journal-title":"J Natl Cancer Inst"},{"issue":"e0165801","key":"key20240417101843_b2-MCO-20-5-02734","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165801","article-title":"Use of complementary and alternative medicine (CAM) as part of the oncological treatment: Survey about patients' attitude towards CAM in a university-based oncology center in Germany","volume":"11","author":"Kessel","year":"2016","journal-title":"PLoS One"},{"key":"key20240417101843_b3-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.3747\/co.25.3884","article-title":"Complementary and alternative medicine use in patients before and after a cancer diagnosis","volume":"25","author":"Buckner","year":"2018","journal-title":"Curr Oncol"},{"key":"key20240417101843_b4-MCO-20-5-02734","author":"Choudhury"},{"key":"key20240417101843_b5-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1177\/1060028020928052","article-title":"Myth busters: Dietary supplements and COVID-19","volume":"54","author":"Adams","year":"2020","journal-title":"Ann Pharmacother"},{"key":"key20240417101843_b6-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.critrevonc.2010.02.012","article-title":"Pazopanib: Clinical development of a potent anti-angiogenic drug","volume":"77","author":"Schutz","year":"2011","journal-title":"Crit Rev Oncol Hematol"},{"issue":"16","key":"key20240417101843_b7-MCO-20-5-02734","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-019-0049-6","article-title":"Pazopanib in advanced soft tissue sarcomas","volume":"4","author":"Lee","year":"2019","journal-title":"Signal Transduct Target Ther"},{"key":"key20240417101843_b8-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1080\/0284186X.2021.1971294","article-title":"A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma","volume":"60","author":"van Meekeren","year":"2021","journal-title":"Acta Oncol"},{"key":"key20240417101843_b9-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"4842","DOI":"10.1200\/JCO.23.00045","article-title":"Outcomes after preoperative chemoradiation with or without pazopanib in non-rhabdomyosarcoma soft tissue sarcoma: A report from Children's oncology group and NRG oncology","volume":"41","author":"Weiss","year":"2023","journal-title":"J Clin Oncol"},{"key":"key20240417101843_b10-MCO-20-5-02734"},{"key":"key20240417101843_b11-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3109\/19390211.2013.859852","article-title":"An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the natural standard research collaboration","volume":"11","author":"Ulbricht","year":"2014","journal-title":"J Diet Suppl"},{"key":"key20240417101843_b12-MCO-20-5-02734","author":"Pembleton"},{"key":"key20240417101843_b13-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1089\/acm.1995.1.361","article-title":"Inhibition of several strains of influenza virus in vitro and reduction of symptoms by an elderberry extract (Sambucus nigra L.) during an outbreak of influenza B Panama","volume":"1","author":"Zakay-Rones","year":"1995","journal-title":"J Altern Complement Med"},{"key":"key20240417101843_b14-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1177\/147323000403200205","article-title":"Randomized study of the efficacy and safety of oral elderberry extract in the treatment of influenza A and B virus infections","volume":"32","author":"Zakay-Rones","year":"2004","journal-title":"J Int Med Res"},{"issue":"182","key":"key20240417101843_b15-MCO-20-5-02734","doi-asserted-by":"publisher","DOI":"10.3390\/nu8040182","article-title":"Elderberry supplementation reduces cold duration and symptoms in air-travellers: A randomized, double-blind placebo-controlled clinical trial","volume":"8","author":"Tiralongo","year":"2016","journal-title":"Nutrients"},{"key":"key20240417101843_b16-MCO-20-5-02734","first-page":"173","article-title":"Poisoning from elderberry juice-California","volume":"33","year":"1984","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key20240417101843_b17-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1097\/FTD.0b013e31815c16f5","article-title":"Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring","volume":"29","author":"Zhou","year":"2007","journal-title":"Ther Drug Monit"},{"key":"key20240417101843_b18-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1002\/ptr.4619","article-title":"In vitro inhibition of CYP3A4 by the multiherbal commercial product Sambucus force and its main constituents Echinacea purpurea and Sambucus nigra","volume":"26","author":"Schr\u00f8der-Aasen","year":"2012","journal-title":"Phytother Res"},{"key":"key20240417101843_b19-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/FPC.0000000000000292","article-title":"PharmGKB summary: Pazopanib pathway, pharmacokinetics","volume":"27","author":"Thorn","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"key20240417101843_b20-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/ptr.5037","article-title":"In vitro inhibition of human CYP1A2, CYP2D6, and CYP3A4 by six herbs commonly used in pregnancy","volume":"28","author":"Langhammer","year":"2014","journal-title":"Phytother Res"},{"key":"key20240417101843_b21-MCO-20-5-02734","author":"Mangla"},{"issue":"e2300110","key":"key20240417101843_b22-MCO-20-5-02734","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00110","article-title":"Should neoadjuvant treatment be adopted more widely for patients with extremity soft tissue sarcoma in low-income countries?","volume":"9","author":"Mangla","year":"2023","journal-title":"JCO Glob Oncol"},{"key":"key20240417101843_b23-MCO-20-5-02734","doi-asserted-by":"publisher","first-page":"4220","DOI":"10.1158\/1078-0432.CCR-08-2740","article-title":"Phase I trial of pazopanib in patients with advanced cancer","volume":"15","author":"Hurwitz","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"239","key":"key20240417101843_b24-MCO-20-5-02734","doi-asserted-by":"publisher","DOI":"10.3390\/ph15020239","article-title":"Black elder and its constituents: Molecular mechanisms of action associated with female reproduction","volume":"15","author":"Kolesarova","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"issue":"104647","key":"key20240417101843_b25-MCO-20-5-02734","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2020.104647","article-title":"Regulatory landscape of dietary supplements and herbal medicines from a global perspective","volume":"114","author":"Thakkar","year":"2020","journal-title":"Regul Toxicol Pharmacol"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T08:24:01Z","timestamp":1713342241000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2024.2734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,3,20]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2024.2734","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"article-number":"36"}}